Back

ST-2 as a predictor of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair

29 August 2016 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 5 - Valvular disease Mitral valve disease ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Oliver Doerr

MVZ CCB Frankfurt und Main-Taunus GbR, Frankfurt am Main (Germany)

26 More presentations in this session

Presentation thumbnail
Doctor K. Nagao (Kyoto, JP)
Abstract
Presentation thumbnail
Doctor E. Wypasek (Cracow, PL)
Abstract Slides
Presentation thumbnail
Doctor P. Balagny (Paris, FR)
Abstract Slides
Presentation thumbnail
Doctor J. Lopez Aguilera (Cordoba, ES)
Abstract Slides
Presentation thumbnail
Doctor A. Mateescu (Bucharest, RO)
Abstract Slides

Access the full session

Session thumbnail
Poster session 5 - Valvular disease

The Event

Event poster

ESC Congress 2016

29 August 2016 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Transcatheter treatment of severe mitral regurgitation in high surgical risk patients: analysis of clinical and echocardiographic data from a referral center
13 December 2024
thumbnail
Congress Presentation
sST2 is a new potential predictor of the response to cardiac resynchronization therapy and of cardiac contractility modulation in patients with chronic heart failure
29 June 2021
thumbnail
Webinar
Structural heart interventions in aortic valvular disease - IC Core Curriculum 2
4 May 2022
thumbnail
Congress Presentation
Relationship between mitral valve echocardiographic parameters and interventional septal reduction therapy success in patients with hypertrophic obstructive cardiomyopathy - a pilot study
10 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources